Research and Markets: Global Bladder Cancer Pipeline Highlights - 2014 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/l34fzf/global_bladder) has announced the addition of the "Global Bladder Cancer Pipeline Highlights - 2014" report to their offering.

The latest report Bladder Cancer Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global bladder cancer market. It covers emerging therapies for bladder cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides bladder cancer pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides bladder cancer pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides bladder cancer pipeline molecules by the Originator Company.

Short-term Launch Highlights:

Find out which bladder cancer pipeline products will be launched in the US and Ex-US till 2017.

SUMMARY:

- Bladder Cancer phase 3 clinical trial pipeline molecules

- Bladder Cancer phase 2 clinical trial pipeline molecules

- Bladder Cancer phase 1 clinical trial pipeline molecules

- Bladder Cancer preclinical research pipeline molecules

- Bladder Cancer discovery stage pipeline molecules

- Bladder Cancer pipeline molecules short-term launch highlights

Key Topics Covered:

1. Bladder Cancer Pipeline by Stages

2. Bladder Cancer Pipeline by Drug Class

3. Bladder Cancer Pipeline by Company

4. Bladder Cancer Phase 3 Clinical Trial Insights

5. Bladder Cancer Phase 2 Clinical Trial Insights

6. Bladder Cancer Phase 1 Clinical Trial Insights

7. Bladder Cancer Preclinical Research Insights

8. Bladder Cancer Discovery Stage Insights

9. Appendix

10. Research Methodology

Tables

Figures

For more information visit http://www.researchandmarkets.com/research/l34fzf/global_bladder

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals